Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,406 | 745 | 81.8% |
| Unspecified | $2,188 | 1 | 13.4% |
| Education | $439.26 | 7 | 2.7% |
| Honoraria | $350.00 | 1 | 2.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $2,188 | 1 | $0 (2023) |
| ABBVIE INC. | $2,187 | 116 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,186 | 114 | $0 (2024) |
| Janssen Biotech, Inc. | $1,240 | 73 | $0 (2024) |
| PFIZER INC. | $953.81 | 57 | $0 (2024) |
| GENZYME CORPORATION | $847.80 | 46 | $0 (2024) |
| Biofrontera Inc. | $580.01 | 11 | $0 (2020) |
| Lilly USA, LLC | $565.36 | 17 | $0 (2023) |
| UCB, Inc. | $518.16 | 20 | $0 (2024) |
| Amgen Inc. | $478.48 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,559 | 150 | Novartis Pharmaceuticals Corporation ($372.26) |
| 2023 | $4,395 | 127 | Eli Lilly and Company ($2,188) |
| 2022 | $1,795 | 94 | ABBVIE INC. ($410.92) |
| 2021 | $1,435 | 78 | AbbVie Inc. ($326.42) |
| 2020 | $1,213 | 62 | Novartis Pharmaceuticals Corporation ($295.45) |
| 2019 | $1,316 | 70 | AbbVie, Inc. ($252.99) |
| 2018 | $1,431 | 62 | Lilly USA, LLC ($227.27) |
| 2017 | $2,239 | 111 | Biofrontera Inc. ($521.44) |
All Payment Transactions
754 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Immunology | ||||||
| 12/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Education | In-kind items and services | $23.50 | General |
| Category: Monoclonal Antibody | ||||||
| 11/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $0.63 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.40 | General |
| Category: Immunology | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Immunology | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.01 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PSOSA (PSORIASIS SPECIAL AREAS) - A US-BASED SINGLE-ARM PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF NAIL AND SCALP PSORIASIS IMPROVEMENT IN PATIENTS TREATED WITH IXEKIZUMAB | Eli Lilly and Company | $2,188 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,365 | 2,216 | $233,037 | $103,994 |
| 2022 | 19 | 2,229 | 4,026 | $385,998 | $167,653 |
| 2021 | 19 | 2,296 | 4,176 | $430,705 | $191,924 |
| 2020 | 20 | 2,042 | 3,510 | $370,795 | $163,643 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 664 | 1,096 | $129,328 | $55,263 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 157 | 187 | $18,326 | $10,756 | 58.7% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Office | 2023 | 62 | 66 | $17,754 | $8,235 | 46.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 75 | 77 | $11,011 | $4,894 | 44.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 60 | 70 | $10,268 | $4,459 | 43.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 98 | 120 | $14,520 | $4,064 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 44 | $6,292 | $3,820 | 60.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 19 | 75 | $5,003 | $2,416 | 48.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 25 | 27 | $4,509 | $2,076 | 46.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 53 | $4,081 | $1,986 | 48.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 26 | 30 | $3,720 | $1,818 | 48.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 65 | 304 | $3,040 | $1,422 | 46.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 12 | 22 | $2,283 | $1,134 | 49.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 26 | $1,534 | $1,080 | 70.4% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 19 | 19 | $1,368 | $572.58 | 41.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 1,220 | 2,345 | $251,770 | $104,791 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 184 | 231 | $22,638 | $13,335 | 58.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 98 | 105 | $15,015 | $6,779 | 45.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 125 | 260 | $11,946 | $6,264 | 52.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 120 | 140 | $16,940 | $4,698 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 47 | $6,721 | $4,214 | 62.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 53 | 64 | $7,841 | $3,759 | 47.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 45 | 48 | $8,016 | $3,347 | 41.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 13 | 14 | $8,176 | $3,019 | 36.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2022 | 43 | 131 | $4,986 | $2,800 | 56.2% |
About Dr. Juan Vasquez, M.D
Dr. Juan Vasquez, M.D is a Dermatology healthcare provider based in Grandville, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1093981607.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juan Vasquez, M.D has received a total of $16,383 in payments from pharmaceutical and medical device companies, with $2,559 received in 2024. These payments were reported across 754 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($13,406).
As a Medicare-enrolled provider, Vasquez has provided services to 7,932 Medicare beneficiaries, totaling 13,928 services with total Medicare billing of $627,214. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology
- Location Grandville, MI
- Active Since 05/03/2008
- Last Updated 07/30/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1093981607
Products in Payments
- TALTZ (Drug) $2,658
- COSENTYX (Biological) $1,098
- EUCRISA (Drug) $938.54
- DUPIXENT (Biological) $886.86
- TREMFYA (Drug) $838.06
- COSENTYX (Drug) $752.46
- Otezla (Drug) $725.73
- SKYRIZI (Biological) $688.37
- Ameluz (Drug) $549.14
- Humira (Biological) $535.95
- HUMIRA (Biological) $482.30
- Sotyktu (Drug) $420.48
- RINVOQ (Biological) $402.17
- VTAMA (Drug) $347.05
- Cimzia (Drug) $341.59
- Tremfya (Drug) $336.06
- DUPIXENT (Drug) $260.34
- SPEVIGO (Drug) $204.58
- EPIDUO FORTE (Drug) $184.18
- Bimzelx (Biological) $176.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Grandville
Mrs. Jayme Heim, Np, NP
Dermatology — Payments: $494,707
Mr. Kurt Vanderveen, Pa-C, PA-C
Dermatology — Payments: $9,498
Mrs. Molly Duiven, Pa C, PA C
Dermatology — Payments: $9,375
Mrs. Amber Kintigh, Pac, PAC
Dermatology — Payments: $4,891
Mr. Ronald Reusch, Pa C, PA C
Dermatology — Payments: $4,699
Dr. Douglas Winstanley, D.o, D.O
Dermatology — Payments: $3,501